Nakanishi, T.; Mizutani, K.; Iida, S.; Matsushima, Y.; Umaoka, A.; Kondo, M.; Habe, K.; Yamanaka, K.
Janus Kinase Inhibitors Ameliorated Gastrointestinal Amyloidosis and Hypoalbuminemia in Persistent Dermatitis Mouse Model. Int. J. Mol. Sci. 2022, 23, 28.
https://doi.org/10.3390/ijms23010028
AMA Style
Nakanishi T, Mizutani K, Iida S, Matsushima Y, Umaoka A, Kondo M, Habe K, Yamanaka K.
Janus Kinase Inhibitors Ameliorated Gastrointestinal Amyloidosis and Hypoalbuminemia in Persistent Dermatitis Mouse Model. International Journal of Molecular Sciences. 2022; 23(1):28.
https://doi.org/10.3390/ijms23010028
Chicago/Turabian Style
Nakanishi, Takehisa, Kento Mizutani, Shohei Iida, Yoshiaki Matsushima, Ai Umaoka, Makoto Kondo, Koji Habe, and Keiichi Yamanaka.
2022. "Janus Kinase Inhibitors Ameliorated Gastrointestinal Amyloidosis and Hypoalbuminemia in Persistent Dermatitis Mouse Model" International Journal of Molecular Sciences 23, no. 1: 28.
https://doi.org/10.3390/ijms23010028
APA Style
Nakanishi, T., Mizutani, K., Iida, S., Matsushima, Y., Umaoka, A., Kondo, M., Habe, K., & Yamanaka, K.
(2022). Janus Kinase Inhibitors Ameliorated Gastrointestinal Amyloidosis and Hypoalbuminemia in Persistent Dermatitis Mouse Model. International Journal of Molecular Sciences, 23(1), 28.
https://doi.org/10.3390/ijms23010028
